GLIS2 and metabolic dysfunction-associated steatotic liver disease: During fibrosis development in MASLD patients, hepatocytes display a loss of their identity characterised by the appearance of a network of transcription factors activated by fibrotic stimuli such as transcription factor Elf‐3 (ELF3) and zinc finger protein GLIS2 (GLIS2).